BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12905796)

  • 1. [Mutations in the D-loop region of mitochondrial DNA in ovarian tumors].
    Shi HH; Vincent L; Hextan N; Yang XY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):170-3. PubMed ID: 12905796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancer.
    Van Trappen PO; Cullup T; Troke R; Swann D; Shepherd JH; Jacobs IJ; Gayther SA; Mein CA
    Gynecol Oncol; 2007 Jan; 104(1):129-33. PubMed ID: 16942794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
    Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
    Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas.
    Liu VW; Shi HH; Cheung AN; Chiu PM; Leung TW; Nagley P; Wong LC; Ngan HY
    Cancer Res; 2001 Aug; 61(16):5998-6001. PubMed ID: 11507041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alterations of mitochondrial DNA in ovarian cancer patients with and without chemotherapy].
    Shi HH; Pan LY; Yang XY; Yuan Y; Yu XD
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):469-71. PubMed ID: 16080874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms, but lack of mutations or instability, in the promotor region of the mitochondrial genome in human colonic tumors.
    Heerdt BG; Chen J; Stewart LR; Augenlicht LH
    Cancer Res; 1994 Jul; 54(14):3912-5. PubMed ID: 8033115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and sequence analysis of the p53 gene mutation in epithelial ovarian cancer].
    Guan X; Lang J; Bian M
    Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):165-7. PubMed ID: 10682487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma.
    Pejovic T; Ladner D; Intengan M; Zheng K; Fairchild T; Dillon D; Easley S; Dillon D; Marchetti D; Schwartz P; Lele S; Costa J; Odunsi K
    Eur J Cancer; 2004 Nov; 40(16):2519-24. PubMed ID: 15519528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of recombinant eukaryotic expression plasmid pcDNA3.1(+)-mtDNA of human colorectal carcinoma cells].
    Wu QQ; Zhang QH; Ma L
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1016-9. PubMed ID: 16109565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
    Lee HC; Li SH; Lin JC; Wu CC; Yeh DC; Wei YH
    Mutat Res; 2004 Mar; 547(1-2):71-8. PubMed ID: 15013701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma.
    Abnet CC; Huppi K; Carrera A; Armistead D; McKenney K; Hu N; Tang ZZ; Taylor PR; Dawsey SM
    BMC Cancer; 2004 Jul; 4():30. PubMed ID: 15230979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer.
    Akouchekian M; Houshmand M; Hemati S; Ansaripour M; Shafa M
    Dis Colon Rectum; 2009 Mar; 52(3):526-30. PubMed ID: 19333057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the mitochondrion DNA mutation in tumor tissues of gynecologic oncology patients].
    Li HX; Zhong S; Li CH
    Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):290-3. PubMed ID: 12895314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors].
    Ma L; Zhang JH; Liu FR; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):657-9. PubMed ID: 16438885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of mitochondrial DNA D-loop region mutation and its significance in human oncocytoma].
    Song WJ; Yan LM; Zhao XL; Liu ZH; Sun BC
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):767-70. PubMed ID: 21163068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome.
    Navaglia F; Basso D; Fogar P; Sperti C; Greco E; Zambon CF; Stranges A; Falda A; Pizzi S; Parenti A; Pedrazzoli S; Plebani M
    Am J Clin Pathol; 2006 Oct; 126(4):593-601. PubMed ID: 16938655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
    Jamieson S; Alexiadis M; Fuller PJ
    Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutations in the D-loop region of mitochondrial DNA and the ROS level in the tissue of hepatocellular carcinoma].
    Huang XW; Zhao Q; Chen DZ; Zhang LS
    Yi Chuan; 2005 Jan; 27(1):14-20. PubMed ID: 15730952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA mutations in chemical carcinogen-induced rat bladder and human bladder cancer.
    Chen GF; Chan FL; Hong BF; Chan LW; Chan PS
    Oncol Rep; 2004 Aug; 12(2):463-72. PubMed ID: 15254717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.